Health Care & Life Sciences » Biotechnology | CK Life Sciences International

CK Life Sciences International | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,971
4,954
4,919
4,869
4,693
5,233
Cost of Goods Sold (COGS) incl. D&A
3,299
3,281
3,267
3,276
3,229
3,558
Gross Income
1,672
1,673
1,652
1,592
1,464
1,675
SG&A Expense
1,351
1,349
1,285
1,275
1,309
1,401
EBIT
321
325
-
-
156
274
Unusual Expense
61
21
132
29
152
151
Non Operating Income/Expense
28
22
68
65
55
113
Interest Expense
104
110
105
96
94
130
Pretax Income
304
321
250
362
330
421
Income Tax
69
48
63
95
49
121
Consolidated Net Income
235
273
186
267
281
301
Net Income
229
264
219
253
258
263
Net Income After Extraordinaries
229
264
219
253
258
263
Net Income Available to Common
229
264
219
253
258
263
EPS (Basic)
0.02
0.03
0.02
0.03
0.03
0.03
Basic Shares Outstanding
9,611
9,611
9,611
9,611
9,611
9,611
EPS (Diluted)
0.02
0.03
0.02
0.03
0.03
0.03
Diluted Shares Outstanding
9,611
9,611
9,611
9,611
9,611
9,611
EBITDA
457
461
522
452
300
412
Non-Operating Interest Income
10
8
3
4
7
12
Minority Interest Expense
6
9
33
14
22
38
Equity in Affiliates (Pretax)
44
56
48
43
54
1

About CK Life Sciences International

View Profile
Address
2 Dai Fu Street
Hong Kong
Hong Kong
Employees -
Website http://www.ck-lifesciences.com
Updated 07/08/2019
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. It operates through the following segments: Agriculture-Related, Health, and Investment. The company was founded on August 10, 2001 and is headquartered in Hong Kong.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.